BlackRock Institutional Trust’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$91M Buy
6,103,002
+332,439
+6% +$4.8M 0.01% 987
2016
Q3
$73.8M Buy
5,770,563
+413,100
+8% +$4.47M 0.01% 1049
2016
Q2
$41.8M Buy
5,357,463
+28,145
+0.5% +$162K 0.01% 1346
2016
Q1
$21.3M Buy
5,329,318
+127,342
+2% +$539K ﹤0.01% 1782
2015
Q4
$29.3M Buy
5,201,976
+310,232
+6% +$1.74M ﹤0.01% 1588
2015
Q3
$27.4M Sell
4,891,744
-1,032,145
-17% -$5.62M ﹤0.01% 1609
2015
Q2
$22.3M Sell
5,923,889
-360,010
-6% -$1.17M ﹤0.01% 1848
2015
Q1
$16.1M Sell
6,283,899
-20,418
-0.3% -$47.4K ﹤0.01% 2078
2014
Q4
$9.08M Sell
6,304,317
-13,152
-0.2% -$20.5K ﹤0.01% 2420
2014
Q3
$9.67M Buy
6,317,469
+639,330
+11% +$2.05M ﹤0.01% 2368
2014
Q2
$19.2M Buy
5,678,139
+173,057
+3% +$598K ﹤0.01% 1985
2014
Q1
$19.5M Buy
5,505,082
+445,491
+9% +$3.03M ﹤0.01% 1982
2013
Q4
$31M Sell
5,059,591
-83,595
-2% -$461K 0.01% 1605
2013
Q3
$29.9M Sell
5,143,186
-176,927
-3% -$916K 0.01% 1562
2013
Q2
$24.2M Buy
+5,320,113
New +$25.2M ﹤0.01% 1660

Other funds holding EXEL

BlackRock Institutional Trust's EXEL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Exelixis (EXEL) stake by 5.8% in Q4 2016, buying an estimated $4.8M and bringing the position to 6,103,002 shares worth $91M. The position accounts for 0.01% of the portfolio, ranked #987.

BlackRock Institutional Trust first reported a position in EXEL in Q2 2013 and has held it in 15 quarters since. 228 funds tracked by Wall St. Rank hold EXEL as of Q4 2016.

  • BlackRock Institutional Trust held 6,103,002 shares of Exelixis worth $91M as of Q4 2016.
  • BlackRock Institutional Trust bought 332,439 Exelixis shares in Q4 2016, an estimated $4.8M.
  • Exelixis made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #987 holding.
  • BlackRock Institutional Trust first reported a position in Exelixis in Q2 2013 and has held it in 15 quarters since.
  • 228 funds tracked by Wall St. Rank held Exelixis as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.